Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO

The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic…

First reported by Hindustan Times 1 source
Image: Hindustan Times
Image: Hindustan Times
Read at Hindustan Times(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. Hindustan Times

    Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO (opens Hindustan Times in a new tab)

    The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of…

Something wrong with how we've grouped or summarised this story? Report a problem